Gates Industrial (GTES)
(Delayed Data from NYSE)
$17.28 USD
-0.32 (-1.82%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $17.28 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth B Momentum B VGM
Price, Consensus and EPS Surprise
GTES 17.28 -0.32(-1.82%)
Will GTES be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GTES based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GTES
GTES Enhances Data Center Solutions With New Cooling Hose
Abercrombie (ANF) Plunges 19% in a Month: Should You Buy Now?
GTES: What are Zacks experts saying now?
Zacks Private Portfolio Services
Gates Industrial (GTES) Tops Q2 Earnings Estimates
Tutor Perini (TPC) and O&G JV Wins Amtrak Bridge Project
KBR's K-GreeN Technology Chosen by OCIOR Energy in India
Other News for GTES
AI emerged as key theme at Morgan Stanley’s industrials conference
GATES EXPANDS DATA CENTER COOLING PORTFOLIO WITH LAUNCH OF NEW DATA MASTER? HOSE
Gates Industrial: Growing Margins Paving Way To A Higher Stock Price
Gates Releases 2023 Corporate Sustainability Report
Gates Industrial initiated with neutral view at Morgan Stanley, here's why